loading

Ligand Pharmaceuticals Inc Borsa (LGND) Ultime notizie

pulisher
Jun 16, 2025

Handelsbanken Fonder AB Has $700,000 Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

Wealth Enhancement Advisory Services LLC Takes $286,000 Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Jun 16, 2025
pulisher
Jun 14, 2025

Cutaneous T-cell Lymphoma Market on Track for Major Expansion by 2034, According to DelveInsight | Innate Pharma, Galderma R&D, Kyowa Kirin, Citius Pharma, Soligenix, 4SC AG, oligenix, Ligand Pharma - Barchart.com

Jun 14, 2025
pulisher
Jun 13, 2025

Rhumbline Advisers Has $6.04 Million Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Ligand Pharmaceuticals CLO Andrew Reardon sells $57,270 in shares - Investing.com Australia

Jun 12, 2025
pulisher
Jun 12, 2025

Ligand Pharmaceuticals CLO Andrew Reardon sells $57,270 in shares By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 11, 2025

3 Companies That May Be Trading Below Their Estimated Value - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

Ligand Announces 2025 Investor Day in New York City | LGND Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Ligand Pharmaceuticals to Host Investor Day in New York City on December 9, 2025 - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Ligand Announces 2025 Investor Day in New York City - Bluefield Daily Telegraph

Jun 11, 2025
pulisher
Jun 10, 2025

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

GAMMA Investing LLC Purchases 61,996 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Jun 10, 2025
pulisher
Jun 05, 2025

Ligand Pharmaceuticals Incorporated to Host Earnings Call - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 03, 2025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ligand Pharmaceuticals Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017LGND - ACCESS Newswire

Jun 03, 2025
pulisher
May 29, 2025

BNP Paribas Financial Markets Cuts Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

May 29, 2025
pulisher
May 26, 2025

Lazard Asset Management LLC Sells 1,507 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

May 26, 2025
pulisher
May 26, 2025

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Bought by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

May 26, 2025
pulisher
May 23, 2025

Bank of America Corp DE Purchases 2,533 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

May 23, 2025
pulisher
May 21, 2025

Executives At Ligand Pharmaceuticals Show Confidence With Major Stock Buys - Finimize

May 21, 2025
pulisher
May 20, 2025

Jane Street Group LLC Sells 1,083 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

May 20, 2025
pulisher
May 20, 2025

Ameriprise Financial Inc. Raises Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

May 20, 2025
pulisher
May 19, 2025

Ligand Rings the Nasdaq Stock Market Opening Bell - Nasdaq

May 19, 2025
pulisher
May 16, 2025

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

May 16, 2025
pulisher
May 14, 2025

Ligand to Ring the Nasdaq Opening Bell on May 19, 2025 - TradingView

May 14, 2025
pulisher
May 14, 2025

The Manufacturers Life Insurance Company Buys 779 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

May 14, 2025
pulisher
May 13, 2025

Ligand Pharmaceuticals Executives Increase Holdings - TradingView

May 13, 2025
pulisher
May 13, 2025

Ligand Pharmaceuticals (NASDAQ:LGND) Downgraded to Sell Rating by StockNews.com - Defense World

May 13, 2025
pulisher
May 12, 2025

LGND: 1Q:25 Results - MSN

May 12, 2025
pulisher
May 11, 2025

Ligand Pharmaceuticals First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 11, 2025
pulisher
May 10, 2025

Oppenheimer Maintains Rating and Raises Price Target for LGND | - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 09, 2025

Oppenheimer Maintains Rating and Raises Price Target for LGND | LGND Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Oppenheimer Raises Price Target for Ligand (LGND) to $145 | LGND Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Oppenheimer Adjusts Ligand Pharmaceuticals Price Target to $145 From $142, Maintains Outperform Rating - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Ligand Pharmaceuticals Inc (LGND) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Ligand Pharmaceuticals Inc (LGND) Q1 2025 Earnings Call Highligh - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Earnings call transcript: Ligand Pharmaceuticals beats Q1 2025 expectations - Investing.com

May 09, 2025
pulisher
May 09, 2025

Ligand Pharmaceuticals Reports Strong Q1 2025 Revenue Growth - TipRanks

May 09, 2025
pulisher
May 08, 2025

Ligand Pharmaceuticals Reports Strong Q1 2025 Earnings - TipRanks

May 08, 2025
pulisher
May 08, 2025

Ligand: Q1 Earnings Snapshot - Huron Daily Tribune

May 08, 2025
pulisher
May 08, 2025

Earnings call transcript: Ligand Pharmaceuticals beats Q1 2025 expectations By Investing.com - Investing.com UK

May 08, 2025
pulisher
May 08, 2025

Ligand Pharmaceuticals Q1 Core Adjusted Earnings, Revenue Increase; Shares Up Pre-Bell - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Ligand (LGND) Upholds 2025 Financial Guidance | LGND Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Ligand Pharmaceuticals Reports Q1 Revenue of $45.3M, Beating Estimates; EPS Falls Short with $2.21 Loss - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Ligand (LGND) Exceeds Revenue Expectations with Strategic Moves - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Ligand (LGND) Exceeds Revenue Expectations with Strategic Moves | LGND Stock News - GuruFocus

May 08, 2025
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):